Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

News notes from neurology meeting

News notes from neurology meeting Significant information about advances in treating or understanding the major neurological diseases always emerges from the annual meeting of the American Academy of Neurology. Here are summaries of some noteworthy reports presented at this year's conference in Chicago. Multiple Sclerosis Treatment of multiple sclerosis (MS) by plasmapheresis was the subject of three reports of varying degrees of enthusiasm. In eight cases of progressive MS so treated, there was "definite evidence of improvement," reported Peter Dau, MD, of Children's Hospital, San Francisco. The treatment comprised one exchange (involving 3 to 5 L of plasma) each week for six to ten weeks. However, Dau said, even though plasmapheresis was continued for nine months, the "bulk of the disability was not improved." Similar observations came from Howard Weiner, MD, of Harvard Medical School, and Floyd Davis, MD, of Rush-Presbyterian-St Luke's Medical Center in Chicago. Weiner, for instance, found "modest but unequivocal" improvement lasting http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

News notes from neurology meeting

JAMA , Volume 242 (4) – Jul 27, 1979

Loading next page...
 
/lp/american-medical-association/news-notes-from-neurology-meeting-GHfB0u6DZL

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Medical Association
Copyright
Copyright © 1979 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.1979.03300040005003
Publisher site
See Article on Publisher Site

Abstract

Significant information about advances in treating or understanding the major neurological diseases always emerges from the annual meeting of the American Academy of Neurology. Here are summaries of some noteworthy reports presented at this year's conference in Chicago. Multiple Sclerosis Treatment of multiple sclerosis (MS) by plasmapheresis was the subject of three reports of varying degrees of enthusiasm. In eight cases of progressive MS so treated, there was "definite evidence of improvement," reported Peter Dau, MD, of Children's Hospital, San Francisco. The treatment comprised one exchange (involving 3 to 5 L of plasma) each week for six to ten weeks. However, Dau said, even though plasmapheresis was continued for nine months, the "bulk of the disability was not improved." Similar observations came from Howard Weiner, MD, of Harvard Medical School, and Floyd Davis, MD, of Rush-Presbyterian-St Luke's Medical Center in Chicago. Weiner, for instance, found "modest but unequivocal" improvement lasting

Journal

JAMAAmerican Medical Association

Published: Jul 27, 1979

There are no references for this article.